Evaluation of Cemiplimab in Combination With Platinum-Doublet Chemotherapy in First-Line (1L) Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) in Adult United States (US) Patients
Clinicaltrials.gov Identifier:All clinical trials available on ClinicalTrials.gov are given an official number by the United States government. This helps people easily search for and find a certain trial.
Trial details
How far along a trial is in the process. There are several phases: Phase 1, Phase 2, Phase 3 and Phase 4.
Trials that are looking for healthy people to participate.
The disease(s) being studied in a trial.
Advanced Non-small Cell Lung Cancer
An interventional trial typically studies a potential medicine. An observational trial watches a person's health over time with no investigational medicine given.
Observational
The new medicine being studied.
REGN2810
The number of people the researchers want in the trial.
1000
Trial summary
This multi-year cohort study will assess the real-world safety and effectiveness of 1L treatment with cemiplimab in combination with platinum-doublet chemotherapy across advanced NSCLC patient subgroups defined by age, sex, race, and ethnicity. Patients will be retrospectively identified from at least two US electronic health record (EHR)-based databases.
Trial locations
0 location(s)